Ugeskrift for laeger
-
Ugeskrift for laeger · Oct 2009
Randomized Controlled Trial[The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].
Results from a phase II trial with Tesofensine for treatment of obesity are presented. In total 203 obese persons were randomised to treatment with Tesofensine 0.25, 0.5, or 1.0 mg, or placebo daily for 24 weeks. ⋯ Tesofensine 0.5 mg might have the potential to produce a weight loss twice that of currently approved anti-obesity drugs. Findings of safety and efficacy of 0.5 mg Tesofensine need confirmation in phase III trials.
-
Ugeskrift for laeger · Oct 2009
[Penetrating trauma treated by the Medical Emergency Care Unit in Copenhagen].
The World Health Organization defines violence as a public health problem, affecting mainly boys and young men. Interpersonal violence with sharp objects and arms is rare in Denmark, but has been the focus of attention from the media and general population. This study describes the incidence and characteristics of penetrating trauma treated by the Medical Emergency Care Unit in Copenhagen (MECU) from 2000 to 2007. ⋯ The incidence of and mortality from penetrating trauma has not been rising in Copenhagen during the last eight years.